RALEIGH, N.C. & LAS VEGAS, September 30, 2025--(BUSINESS WIRE)--QHP Capital ("QHP") today announced an investment in Vector Clinical Trials ("Vector" or the "Company"), a leading clinical research ...
We previously published a report on the scale-up and manufacturing of clinical-grade SIN gRV vectors by transient transfection in a closed-system bioreactor in which we identified optimized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback